Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:2187-2196, doi:10.1016/j.jacc.2009.04.100
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Ma, H.
Right arrow Articles by Ren, J.
PubMed
Right arrow Articles by Ma, H.
Right arrow Articles by Ren, J.
Related Collections
Right arrowRelated Articles

PRE-CLINICAL RESEARCH

Aldehyde Dehydrogenase 2 Ameliorates Acute Cardiac Toxicity of Ethanol

Role of Protein Phosphatase and Forkhead Transcription Factor

Heng Ma, MD, PhD*,{ddagger}, Ji Li, PhD{ddagger}, Feng Gao, MD, PhD*,{dagger} and Jun Ren, MD, PhD*,{dagger},{ddagger},*

* Department of Physiology, Fourth Military Medical University, Xi'an, China
{dagger} Xijing Hospital, Fourth Military Medical University, Xi'an, China
{ddagger} Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, Wyoming

Manuscript received October 28, 2008; revised manuscript received March 10, 2009, accepted April 2, 2009.

* Reprint requests and correspondence: Dr. Jun Ren, University of Wyoming College of Health Sciences, 1000 East University Avenue, Laramie, Wyoming 82071 (Email: jren{at}uwyo.edu).

Objectives: This study was designed to evaluate the role of facilitated detoxification of acetaldehyde, the main metabolic product of ethanol, through systemic overexpression of mitochondrial aldehyde dehydrogenase-2 (ALDH2) on acute ethanol exposure-induced myocardial damage.

Background: Binge drinking may exert cardiac toxicity and interfere with heart function, manifested as impaired ventricular contractility, although the underlying mechanism remains poorly defined.

Methods: ALDH2 transgenic mice were produced using the chicken beta-actin promoter. Wild-type FVB (friend virus B) and ALDH2 mice were challenged with ethanol (3 g/kg, intraperitoneally), and cardiac function was assessed 24 h later using the Langendroff and cardiomyocyte edge-detection systems. Western blot analysis was used to evaluate protein phosphatase 2A and 2C (PP2A and PP2C), phosphorylation of Akt, AMP-activated protein kinase (AMPK), and the transcription factors Foxo3 (Thr32 and Ser413).

Results: ALDH2 reduced ethanol-induced elevation in cardiac acetaldehyde levels. Acute ethanol challenge deteriorated myocardial and cardiomyocyte contractile function evidenced by reduction in maximal velocity of pressure development and decline (±dP/dt), left ventricular developed pressure, cell shortening, and prolonged relengthening duration, the effects of which were alleviated by ALDH2. Ethanol treatment dampened phosphorylation of Akt and AMPK associated with up-regulated PP2A and PP2C, which was abrogated by ALDH2. ALDH2 significantly attenuated ethanol-induced decrease in Akt- and AMPK-stimulated phosphorylation of Foxo3 at Thr32 and Ser413, respectively. Consistently, ALDH2 rescued ethanol-induced myocardial apoptosis, protein damage, and mitochondrial membrane potential depolarization.

Conclusions: Our results suggest that ALDH2 is cardioprotective against acute ethanol toxicity, possibly through inhibition of protein phosphatases, leading to enhanced Akt and AMPK activation, and subsequently, inhibition of Foxo3, apoptosis, and mitochondrial dysfunction.

Key Words: ethanol • ALDH2 • myocardial dysfunction • Akt • AMPK • Foxo3 • protein phosphatase

Abbreviations and Acronyms
  ±dL/dt = maximal velocity of shortening/relengthening
  ±dP/dt = maximal velocity of pressure development and decline
  ADH = alcohol dehydrogenase
  ALDH = aldehyde dehydrogenase
  AMPK = AMP-activated protein kinase
  LVDP = left ventricular developed pressure
  PS = peak shortening
  SR = sarcoplasmic reticulum
  TPS = time-to-90% peak shortening
  TR90 = time-to-90% relengthening
  {Delta}{Psi}m = mitochondrial membrane potential


Related Articles

Lessons From the Besotted Heart
Joel S. Karliner
J. Am. Coll. Cardiol. 2009 54: 2197-2198. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A38. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. S. Karliner
Lessons From the Besotted Heart.
J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2197 - 2198.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement